KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Dividends Paid - Common (2016 - 2025)

Historic Dividends Paid - Common for Encompass Health (EHC) over the last 17 years, with Q3 2025 value amounting to $19.4 million.

  • Encompass Health's Dividends Paid - Common rose 1279.07% to $19.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $109.0 million, marking a year-over-year increase of 3625.0%. This contributed to the annual value of $125.0 million for FY2024, which is 897.99% up from last year.
  • As of Q3 2025, Encompass Health's Dividends Paid - Common stood at $19.4 million, which was up 1279.07% from $17.2 million recorded in Q2 2025.
  • In the past 5 years, Encompass Health's Dividends Paid - Common ranged from a high of $39.5 million in Q4 2024 and a low of $14.9 million during Q4 2022
  • In the last 5 years, Encompass Health's Dividends Paid - Common had a median value of $27.6 million in 2021 and averaged $25.0 million.
  • Its Dividends Paid - Common has fluctuated over the past 5 years, first plummeted by 8207.02% in 2021, then skyrocketed by 7324.56% in 2024.
  • Over the past 5 years, Encompass Health's Dividends Paid - Common (Quarter) stood at $27.7 million in 2021, then crashed by 46.21% to $14.9 million in 2022, then skyrocketed by 53.02% to $22.8 million in 2023, then soared by 73.25% to $39.5 million in 2024, then tumbled by 50.89% to $19.4 million in 2025.
  • Its Dividends Paid - Common was $19.4 million in Q3 2025, compared to $17.2 million in Q2 2025 and $32.9 million in Q1 2025.